Wearable device to reduce fat in diabetics. Source Kumamoto University

A new wearable smart device has been developed by scientists in Japan to help obese diabetics lose fat.

The device has been developed by researchers from Kumamoto University and it attacks the visceral fat as well as improves blood glucose levels.

Type 2 diabetes occurs when excess visceral fat in a body leads to hyperglycemia, a metabolic disorder, which in turn reduces the stress resistance of the human body. This affects the ability of insulin to lower blood sugar levels.

To counter this, the heat stroke response (HSR) is activated in the human body. But obesity prevents the proteins produced from HSRs to stimulate the insulin. The research team found an effective treatment for this.

They found that a combination of mild electrical stimulation (MES) with heat shock waves works more efficiently on insulin. They developed a belt-type device which uses a special type of rubber that transmits MES and HS together. They tested this on 40 obese men suffering from type 2 diabetes. The results were positive as they showed a fall in glucose levels and loss in visceral fat. It also had a therapeutic effect on the patients.

Another clinical trial was conducted, this time on 60 obese patients, both men and women, with type 2 diabetes. The trial went on for 12 weeks. Patients were divided into 3 groups depending on a 60-minute treatment for  2, 4 and 7 sittings per week. Improvements were seen in chronic inflammation, fatty liver markers, renal function and lipid profileof patients who received the maximum sittings.

Tatsuya Kondo, who iled the research, said, “This device is very easy to use since it simply attaches to the abdomen, and it has a low-impact on the patient. One can expect the effects to be similar to exercise therapy.”

He also mentioned, “Even in patients who have difficulty exercising, such as those who are overweight, elderly, or have some form of disability, this device can be expected to provide acceptable treatment in addition to conventional diabetic medical care.”

The research was published in the journal, Scientific Reports.